Skip to main navigation Skip to search Skip to main content

Author Correction: The endocannabinoid N-arachidonoyl dopamine is critical for hyperalgesia induced by chronic sleep disruption (Nature Communications, (2023), 14, 1, (6696), 10.1038/s41467-023-42283-6)

  • Weihua Ding
  • , Liuyue Yang
  • , Eleanor Shi
  • , Bowon Kim
  • , Sarah Low
  • , Kun Hu
  • , Lei Gao
  • , Ping Chen
  • , Wei Ding
  • , David Borsook
  • , Andrew Luo
  • , Jee Hyun Choi
  • , Changning Wang
  • , Oluwaseun Akeju
  • , Jun Yang
  • , Chongzhao Ran
  • , Kristin L. Schreiber
  • , Jianren Mao
  • , Qian Chen
  • , Guoping Feng
  • Shiqian Shen
  • Harvard University
  • Tufts University
  • Brandeis University
  • Korea Institute of Science and Technology
  • Massachusetts Institute of Technology
  • CAS - Shanghai Institute of Materia Medica

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

Correction to: Nature Communications, published online 25 October 2023 In this article, the affiliation details for Guoping Feng were incorrectly given as ‘Zhongshan Institute for Drug Discovery, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai, China’ but should have been ‘McGovern Institute for Brain Research and Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA, USA’. The original article has been corrected.

Original languageEnglish
Article number7342
JournalNature Communications
Volume14
Issue number1
DOIs
StatePublished - Dec 2023

ASJC Scopus Subject Areas

  • General Chemistry
  • General Biochemistry,Genetics and Molecular Biology
  • General Physics and Astronomy

Fingerprint

Dive into the research topics of 'Author Correction: The endocannabinoid N-arachidonoyl dopamine is critical for hyperalgesia induced by chronic sleep disruption (Nature Communications, (2023), 14, 1, (6696), 10.1038/s41467-023-42283-6)'. Together they form a unique fingerprint.

Cite this